Hosted on Acast. See acast.com/privacy for more information.
Hosted on Acast. See acast.com/privacy for more information.
Take our post-test to claim CME credits.
To listen to our full-length podcast, click here.
Hosted on Acast. See acast.com/privacy for more information.
Take our post-test to claim CME credits.
To listen to our full-length podcast, click here.
Hosted on Acast. See acast.com/privacy for more information.
Take our post-test to claim CME credits.
To listen to our full-length podcast, click here.
Hosted on Acast. See acast.com/privacy for more information.
Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them for tomorrow. That’s the focus of this Special HBV Edition of eViralHepatitis Review.
The first part of this program presented an evidence-based expert commentary by eViralHepatitis Review Program Director Dr. Mark Sulkowski — Professor of Medicine at Johns Hopkins and Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. This second part is an interview providing more in-depth discussions between Dr. Sulkowski and three of medicine’s top CHB experts.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Hosted on Acast. See acast.com/privacy for more information.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Why has finding a cure for hepatitis B infection been so challenging? What is it about this virus and its life cycle that makes it so different from curable HCV? In this issue, Dr. Marion Peters from the University of California San Francisco and Northwestern University explains the obstacles researchers face in their quest to tame this virus.
Hosted on Acast. See acast.com/privacy for more information.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Hepatitis C has become “curable” for >90% of those infected. But while universal HCV elimination is medically possible, this goal is compromised by certain populations who remain underscreened, undertreated, and underserved and continue to spread the virus. One such population is people who inject drugs (PWID).
In this issue, Dr. Brianna Norton and Dr. Matthew Akiyama from the Albert Einstein College of Medicine analyze the most important data to explain how substance use impacts adherence and the risk of HCV reinfection.
Hosted on Acast. See acast.com/privacy for more information.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
The extrahepatic manifestations of chronic HCV can affect many different organ systems. In this eViralHepatitis Review podcast, Dr. Rajender Reddy from the University of Pennsylvania’s Perelman School of Medicine discusses clinical approaches to identifying and managing the effects of HCV infection beyond the liver.
Hosted on Acast. See acast.com/privacy for more information.
In this issue, Drs. Jordan Feld and Lisette Krassenburg from the Toronto Centre for Liver Disease at the University of Toronto apply the information in their recent newsletter issue to clinical practice.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Hosted on Acast. See acast.com/privacy for more information.
In this podcast follow-up to their recent eViralHepatitis Review newsletter issue (Vol. 6, No. 5), Dr. Mandana Khalili and Dr. Michele Tana from the University of California, San Francisco discuss how their analysis of the newer published information can impact clinical practice.
Take our post-test to claim CME credits.
To read a companion newsletter click here
Hosted on Acast. See acast.com/privacy for more information.
People who inject drugs (PWID) comprise a rapidly growing population of HCV-infected people who have historically been difficult to reach and treat. But without engagement in HCV care, PWID will continue to transmit the virus and impede efforts for hepatitis C eradication.
In this issue, Dr. Arthur Kim from Massachusetts General Hospital and Harvard Medical School provides a clinical perspective on identifying and overcoming the barriers that prevent PWID from effectively receiving HCV treatment.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Hosted on Acast. See acast.com/privacy for more information.
Among the many extrahepatic complications of hepatitis C infection that contribute to increased morbidity and mortality are CV (cryoglobulinemic vasculitis) and CKD chronic kidney disease).
In this issue, Dr. Paul Martin and Dr. Kalyan Ram Bhamidimarri from the Miller School of Medicine at the University of Miami discuss identification and management of these HCV-related comorbidities.
To read a companion newsletter click here.
Hosted on Acast. See acast.com/privacy for more information.
Volume 5, Issue 12.
In this podcast Dr. Ira Jacobson discusses New Options for Patients with “Hard-To-Treat” Hepatitis C Infection.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post New Options for Patients with “Hard-To-Treat” Hepatitis C Infection appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 5, Issue 10.
In this podcast Dr. David Wyles discusses managing DAA failures with the newly approved treatment options for hepatitis C.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post Using Real World Data to Individualize HCV Management appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 5, Issue 8.
In this podcast, Andrew J. Muir, MD from Duke University School of Medicine discusses the real-world data to support a sofosbuvir-ledipasvir treatment duration of 8 weeks versus 12 weeks, summarizes the current hepatitis C treatment options for patients with advanced kidney disease, and describes the risks and benefits of hepatitis C therapies in HIV-HCV coinfected patients.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post Using Real World Data to Individualize HCV Management appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 5, Issue 6.
This podcast, Andrew H. Talal, MD, MPH and Richard Blondell, MD from the University at Buffalo discuss expanding HCV screening in persons with substance abuse disorders.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post Clinical Insights: HCV and Substance Use Disorder appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 5, Issue 4.
In this podcast Daryl T. Y. Lau, MD, MSc, MPH from Harvard Medical School discussed how to evaluate and mange patients who do not meet treatment criteria, the management of chronic hepatitis B during pregnancy, and how to identify patients appropriate for tenofovir alafenamide (TAF) therapy.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post Clinical Approaches to HBV Therapy appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 5, Issue 2.
Our guests authors are Mindie Nguyen, MD, MAS, from Associate Professor of Medicine at Stanford University, and Dr. Iris Liou, MD of the University of Washington.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post HBV: Addressing Current Gaps in Diagnosis and Linkage to Care appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 4, Issue 14.
Drs Jordan Feld, MD, MPH and Joel Emery, HBSc, MD cover the important topic of Extrahepatic Manifestations of Hepatitis C: Screening and Management in the format of case-study scenarios for the clinical practice.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post Extrahepatic Manifestations of Hepatitis C: Screening and Management appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 4, Issue 12.
Our guest author is Chloe Thio, MD, Professor of Medicine, Divison of Infectious Diseases at the Johns Hopkins University School of Medicine.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post Emerging Therapeutic Approaches for Chronic Hepatitis B appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
Volume 4, Issue 10.
Drs Kenneth Sherman, MD, PhD and Nadeem Anwar, MD cover the important topic of New Approaches to the Diagnosis and Management of Chronic HBV Infection in the format of case-study scenarios for the clinical practice.
Take our post-test to claim CME credits:
Physician post-test
Nurse post-test
To read a companion newsletter click here.
The post New Approaches to the Diagnosis and Management of Chronic HBV Infection appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
